A nomogram predicting the risk of venous thromboembolism in patients following urologic surgeries
- PMID: 39748087
- PMCID: PMC11695610
- DOI: 10.1038/s41598-024-84681-w
A nomogram predicting the risk of venous thromboembolism in patients following urologic surgeries
Abstract
There are inconsistent results pertaining to risk factors for venous thromboembolism (VTE) in patients following urologic surgeries. We attempted to establish a visualization model to shed further light upon this topic. Consequently, a total of 436 patients who were tested for VTE following urologic surgeries were retrospectively enrolled. Least absolute shrinkage and selection operator method (LASSO) method was utilized to determine risk factors for VTE and a subsequent nomogram was constructed. The concordance index (C-index) and calibration curve were utilized to evaluate the nomogram. The results suggested that age, history of smoking, D-dimer levels on the first postoperative day, transfusion volume and body mass index (BMI) were identified as significant risk factors for VTE. The C-index of the nomogram composed of the five variables was 0.747 (95% CI 0.700-0.793) and the calibration plot demonstrated good performance. Therefore, the present nomogram could predict the risk of VTE following urologic surgeries.
Keywords: Cohort study; LASSO analysis; Nomogram; Urologic surgeries; Venous thromboembolism.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures



Similar articles
-
Postoperative D-dimer predicts venous thromboembolism in patients undergoing urologic tumor surgery.Urol Oncol. 2018 Jun;36(6):307.e15-307.e21. doi: 10.1016/j.urolonc.2018.03.003. Epub 2018 Mar 26. Urol Oncol. 2018. PMID: 29599070
-
Development and validation of a multi-parameter nomogram for venous thromboembolism in gastric cancer patients: a retrospective analysis.PeerJ. 2024 Jun 25;12:e17527. doi: 10.7717/peerj.17527. eCollection 2024. PeerJ. 2024. PMID: 38948205 Free PMC article.
-
Development and validation of a nomogram model for predicting venous thromboembolism risk in lung cancer patients treated with immune checkpoint inhibitors: A cohort study in China.Cancer Med. 2024 Aug;13(16):e70115. doi: 10.1002/cam4.70115. Cancer Med. 2024. PMID: 39162396 Free PMC article.
-
Perioperative venous thromboembolism in urologic oncology procedures, risk factors, and prevention.Curr Opin Urol. 2018 May;28(3):227-232. doi: 10.1097/MOU.0000000000000491. Curr Opin Urol. 2018. PMID: 29465471 Review.
-
The role of extended venous thromboembolism prophylaxis following urologic pelvic surgery.Urol Oncol. 2018 Mar;36(3):83-87. doi: 10.1016/j.urolonc.2017.12.010. Epub 2018 Jan 12. Urol Oncol. 2018. PMID: 29336977 Review.
References
-
- Gangireddy, C. et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J. Vasc. Surg.45, 335–341. 10.1016/j.jvs.2006.10.034 (2007). - PubMed
-
- VanDlac, A. A. et al. Timing, incidence and risk factors for venous thromboembolism in patients undergoing radical cystectomy for malignancy: a case for extended duration pharmacological prophylaxis. J. Urol.191, 943–947. 10.1016/j.juro.2013.10.096 (2014). - PubMed
-
- Alberts, B. D. et al. Venous thromboembolism after major urologic oncology surgery: a focus on the incidence and timing of thromboembolic events after 27,455 operations. Urology84, 799–806. 10.1016/j.urology.2014.05.055 (2014). - PubMed
-
- Heit, J. A. et al. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch. Intern. Med.159, 445–453. 10.1001/archinte.159.5.445 (1999). - PubMed
-
- Huerta, C., Johansson, S., Wallander, M. A. & García Rodríguez, L. A. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch. Intern. Med.167, 935–943. 10.1001/archinte.167.9.935 (2007). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources